Scholl PR[au] - Search Results

Year	Number of Results
1989	1
1990	2
1992	2
1993	1
1994	3
1995	2
1997	1
1998	3
2000	1
2001	1
2002	2
2003	1
2016	1
2022	0

1

Periodic fever syndromes.

Scholl PR. Scholl PR. Curr Opin Pediatr. 2000 Dec;12(6):563-6. doi: 10.1097/00008480-200012000-00009. Curr Opin Pediatr. 2000. PMID: 11106276 Review.

2

MHC class II signaling in B-cell activation.

Scholl PR, Geha RS. Scholl PR, et al. Immunol Today. 1994 Sep;15(9):418-22. doi: 10.1016/0167-5699(94)90271-2. Immunol Today. 1994. PMID: 7524519 Review.

3

Hyper IgM Syndrome: a Report from the USIDNET Registry.

Leven EA, Maffucci P, Ochs HD, Scholl PR, Buckley RH, Fuleihan RL, Geha RS, Cunningham CK, Bonilla FA, Conley ME, Ferdman RM, Hernandez-Trujillo V, Puck JM, Sullivan K, Secord EA, Ramesh M, Cunningham-Rundles C. Leven EA, et al. Among authors: scholl pr. J Clin Immunol. 2016 Jul;36(5):490-501. doi: 10.1007/s10875-016-0291-4. Epub 2016 May 17. J Clin Immunol. 2016. PMID: 27189378 Free PMC article.

4

Progressive encephalopathy in primary immunodeficiency disease.

Scholl PR. Scholl PR. Clin Immunol. 2002 Jan;102(1):1. doi: 10.1006/clim.2001.5158. Clin Immunol. 2002. PMID: 11781060 No abstract available.

5

The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.

Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. Winkelstein JA, et al. Among authors: scholl pr. Medicine (Baltimore). 2003 Nov;82(6):373-84. doi: 10.1097/01.md.0000100046.06009.b0. Medicine (Baltimore). 2003. PMID: 14663287 Free article.

6

Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome.

Chang MW, Romero R, Scholl PR, Paller AS. Chang MW, et al. Among authors: scholl pr. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):191-6. doi: 10.1016/s0190-9622(98)70239-7. J Am Acad Dermatol. 1998. PMID: 9486673

7

CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability.

Lobo FM, Scholl PR, Fuleihan RL. Lobo FM, et al. Among authors: scholl pr. J Immunol. 2002 Feb 1;168(3):1473-8. doi: 10.4049/jimmunol.168.3.1473. J Immunol. 2002. PMID: 11801691 Free article.

8

Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1.

Scholl PR, Trede N, Chatila TA, Geha RS. Scholl PR, et al. J Immunol. 1992 Apr 1;148(7):2237-41. J Immunol. 1992. PMID: 1545128

9

Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.

Scholl PR, Sekaly RP, Diez A, Glimcher LH, Geha RS. Scholl PR, et al. Eur J Immunol. 1990 Sep;20(9):1911-6. doi: 10.1002/eji.1830200907. Eur J Immunol. 1990. PMID: 2209697

10

Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.

Scholl PR, Diez A, Karr R, Sekaly RP, Trowsdale J, Geha RS. Scholl PR, et al. J Immunol. 1990 Jan 1;144(1):226-30. J Immunol. 1990. PMID: 2404064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results